An ongoing crisis and evolving new working habits of industry executives call for an entirely new and...
COVID-19
Rapid tests have received a lot of attention during the Coronavirus pandemic, but as the number of tests...
Viral pandemics are not a once-in-a-lifetime event but a constant threat looming over our heads. While the...
Oncolytic viruses, viral vectors for gene therapy and viral-vectored prophylactic vaccines, are new,...
As the process determines the product, product characteristics of biological drugs need to be analysed...
A biosimilar is a copy version of an approved, original biological medice whose patent protection has expired....
Viennese APEIRON Biologics AG raised €17.5m to expand ongoing Phase II trials of its
coronavirus-specific drug...
Share
